Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

Tianjin Medical University Second Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
immunotherapyliquid-biopsy
bladder (urothelial, transitional cell) cancer, non muscle invasive bladder cancer, non-muscle-invasive bladder cancer (nmibc), liquid biopsy, immunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834389
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.